To the best of our knowledge, this study is the first to report the relationship between baseline levels of cystatin C and COVID-19 outcomes, and to highlight the prognostic values of monitoring serum cystatin C on hospitalized patients with SARS-CoV-2 infection. Here, CST3 is linked to COVID-19.